Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives

Autor: Zhen-Bin Han, Jian Wang, Yang Liu, Zuo-Peng Zhang, Hua-sheng Su, Ye Zhong, Maosheng Cheng, Lin Zhou
Rok vydání: 2021
Předmět:
0301 basic medicine
QH301-705.5
Cell Survival
Carbohydrates
Inhibitory postsynaptic potential
Catalysis
Article
Polar surface area
Inorganic Chemistry
03 medical and health sciences
0302 clinical medicine
Cell Line
Tumor

Thiadiazoles
Tumor Microenvironment
Humans
Viability assay
Physical and Theoretical Chemistry
Biology (General)
Carbonic Anhydrase Inhibitors
Molecular Biology
QD1-999
Spectroscopy
CA IX inhibitors
Carbonic Anhydrases
chemistry.chemical_classification
Sulfonamides
saccharide
Chemistry
Organic Chemistry
tail approach
Molecular Docking Analysis
General Medicine
Combinatorial chemistry
Computer Science Applications
Sulfonamide
Molecular Docking Simulation
030104 developmental biology
pH of the tumor cell microenvironment
Cell culture
030220 oncology & carcinogenesis
Enzyme inhibitory
HT29 Cells
Human cancer
Zdroj: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 5482, p 5482 (2021)
Volume 22
Issue 11
ISSN: 1422-0067
Popis: A series of saccharide-modified thiadiazole sulfonamide derivatives has been designed and synthesized by the “tail approach” and evaluated for inhibitory activity against carbonic anhydrases II, IX, and XII. Most of the compounds showed high topological polar surface area (TPSA) values and excellent enzyme inhibitory activity. The impacts of some compounds on the viability of HT-29, MDA-MB-231, and MG-63 human cancer cell lines were examined under both normoxic and hypoxic conditions, and they showed certain inhibitory effects on cell viability. Moreover, it was found that the series of compounds had the ability to raise the pH of the tumor cell microenvironment. All the results proved that saccharide-modified thiadiazole sulfonamides have important research prospects for the development of CA IX inhibitors.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje